Stockreport

Trevi Therapeutics Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Updates [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF Trevi Therapeutics, Inc. Following the End-of-Phase 2 meeting with the FDA, the Company gained alignment on its Phase 3 program for the treatment of patients with idi [Read more]